Metraipolis › archive › dc_ab02ccaba5d2

Integrative precision oncology in neuroblastoma: multi-omics biomarkers, molecular targets, and immunotherapeutic strategies — Europe PMC PMID:42558335

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42558335
DOI: 10.3389/fonc.2026.1879586
License (as archived): solo-consultazione
Archived: 2026-10-17T23:55:30.486Z
SHA-256 of the archived text: 1e96cedb14556b05fb4d40f72e04089a8f890ace2b6741772973fba9f6a625be
Stable URL of this page: https://metraipolis.com/documento/dc_ab02ccaba5d2

How to cite

Integrative precision oncology in neuroblastoma: multi-omics biomarkers, molecular targets, and immunotherapeutic strategies — Europe PMC PMID:42558335 — Europe PMC (en), https://europepmc.org/article/MED/42558335 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab02ccaba5d2 (Metraipolis archive dc_ab02ccaba5d2, sha256 1e96cedb14556b05fb4d40f72e04089a8f890ace2b6741772973fba9f6a625be)

BibTeX

@misc{dcab02ccaba5d2,
  title = {Integrative precision oncology in neuroblastoma: multi-omics biomarkers, molecular targets, and immunotherapeutic strategies — Europe PMC PMID:42558335},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42558335},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab02ccaba5d2; sha256 1e96cedb14556b05fb4d40f72e04089a8f890ace2b6741772973fba9f6a625be},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42558335. Agents can read the archived copy with the MCP tool read_document.